Skip to main content
RPRX
NASDAQ Life Sciences

Royalty Pharma Commits $100M to Zealand's Rusfertide

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$59.22
Mkt Cap
$34.055B
52W Low
$34.081
52W High
$60.44
52W Position info
74% above low
Off High info
2.0% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

RPRX sits 74% above its 52-week low of $34.081.

Summary

Royalty Pharma is putting $100 million into Zealand Pharma's rusfertide, a late-stage drug for polycythemia vera. This is a new royalty-style funding deal, not a rehash of prior news. The company has been active in expanding its royalty portfolio, and this adds a meaningful asset. The deal size is modest relative to Royalty Pharma's $34 billion market cap, but it signals continued deal flow. Watch for further details on the royalty rate and milestone structure.

At the time of this announcement, RPRX was trading at $59.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $34.1B. The 52-week trading range was $34.08 to $60.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RPRX - Latest Insights

RPRX
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $66.20
Real-time Price: $68.20 info
Change: +$2.00 (+3%) info
Market Cap: $38.848B info
RPRX
Nov 04, 2026, 7:38 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $66.40
Real-time Price: $68.20 info
Change: +$1.80 (+3%) info
Market Cap: $38.848B info
RPRX
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $66.58
Real-time Price: $68.20 info
Change: +$1.62 (+2%) info
Market Cap: $38.848B info
RPRX
Aug 05, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $57.69
Real-time Price: $68.20 info
Change: +$10.51 (+18%) info
Market Cap: $38.848B info
RPRX
Aug 05, 2026, 7:56 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $58.62
Real-time Price: $68.20 info
Change: +$9.58 (+16%) info
Market Cap: $38.848B info